Search
                    Multiple Myeloma and Plasma Cell Neoplasm Clinical Trials
A listing of 3  Multiple Myeloma and Plasma Cell Neoplasm  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 3 of 3
        
        
    
                There are currently 3 active clinical trials seeking participants for Multiple Myeloma and Plasma Cell Neoplasm research studies. The states with the highest number of trials for Multiple Myeloma and Plasma Cell Neoplasm participants are Ohio, Minnesota, Illinois and California.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
                                
            
            
        Recruiting
                            
            
                RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment.
PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                07/02/2025
            
            Locations: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan         
        
        
            Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
        
            
        
    
                
                                    Registry of Older Patients With Cancer
                                
            
            
        Recruiting
                            
            
                RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future.
PURPOSE: This research study is gathering information from older patients with cancer into a registry.             
        
        
    Gender:
                ALL
            Ages:
                65 years and above
            Trial Updated:
                06/24/2025
            
            Locations: Seby B. Jones Cancer Center, Boone, North Carolina  +6 locations         
        
        
            Conditions: Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
        
            
        
    
                
                                    Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
                                
            
            
        Recruiting
                            
            
                RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                10/18/2024
            
            Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina         
        
        
            Conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonmalignant Neoplasm
        
            
        
    1 - 3 of 3
            
            
        